Literature DB >> 15860506

The initiation of colon cancer in a chronic inflammatory setting.

Ru Chen1, Peter S Rabinovitch, David A Crispin, Mary J Emond, Mary P Bronner, Teresa A Brentnall.   

Abstract

Chronic inflammation predisposes to cancer. We used an inflammation-induced human model of tumorigenesis to explore how populations of mutated cells expand and initiate the earliest stages of cancer. Ulcerative colitis (UC) is a chronic inflammatory disease of the colon associated with an increased risk of colorectal cancer mediated through a process of genomic instability. In order to characterize the process of clonal expansion, arbitrary primed (AR) and inter-simple sequence repeat (ISSR) PCR DNA fingerprint mutation profiles of single crypts were compared with the mutational profiles from clusters of crypts and whole biopsies within the same individual. To provide information at the earliest steps of neoplastic progression, we examined histologically negative crypts, as well as dysplastic crypts. Crypts from UC dysplasia/cancer show alterations in 10-20% of DNA fingerprint sites, regardless of (i) whether the crypts were dysplastic or non-dysplastic and (ii) whether the DNA came from one crypt or thousands of crypts. Of the mutational changes in single crypts, almost half are clonally expanded to adjacent crypts and/or to the thousands of crypts in a single biopsy. Using fluorescent in-situ hybridization to examine p53 alterations in individual crypt cells, we demonstrate that the mechanism of clonal expansion can occur through crypt fission. DNA alterations are initiated in colonic crypts and expand to adjacent crypts through crypt fission. Our data suggest that a continuous process of DNA mutations, clonal expansion through crypt fission and clonal succession initiates the development of inflammatory-associated colon cancer; this mutational process is moderated by crypt cell turn-over and cell death. This paradigm may apply to other inflammatory-induced cancers.

Entities:  

Mesh:

Year:  2005        PMID: 15860506     DOI: 10.1093/carcin/bgi106

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  22 in total

Review 1.  To best measure cell proliferation in samples from the intestine.

Authors:  D Alferez; R A Goodlad
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

Review 2.  Precancer in ulcerative colitis: the role of the field effect and its clinical implications.

Authors:  Kathryn T Baker; Jesse J Salk; Teresa A Brentnall; Rosa Ana Risques
Journal:  Carcinogenesis       Date:  2018-01-12       Impact factor: 4.944

3.  Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.

Authors:  Kan Yang; Natalia V Popova; Wan Cai Yang; Ioanna Lozonschi; Selam Tadesse; Scott Kent; Laura Bancroft; Ilze Matise; Robert T Cormier; Stefan J Scherer; Winfried Edelmann; Martin Lipkin; Leonard Augenlicht; Anna Velcich
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

4.  Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer.

Authors:  Lisa A Lai; Rosa Ana Risques; Mary P Bronner; Peter S Rabinovitch; David Crispin; Ru Chen; Teresa A Brentnall
Journal:  Cancer Lett       Date:  2012-03-02       Impact factor: 8.679

5.  The co-localization of carcinomas and adenomas favors a regional field defect in the colon: an observational study.

Authors:  Isadora Rosa; Paulo Fidalgo; Paula Chaves; António D Pereira
Journal:  Int J Colorectal Dis       Date:  2014-12-10       Impact factor: 2.571

Review 6.  Genetic and clinical aspects of wood dust related intestinal-type sinonasal adenocarcinoma: a review.

Authors:  José Luis Llorente; Jhudit Pérez-Escuredo; César Alvarez-Marcos; Carlos Suárez; Mario Hermsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-17       Impact factor: 2.503

7.  Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.

Authors:  Mary P Bronner; Jacintha N O'Sullivan; Peter S Rabinovitch; David A Crispin; Lu Chen; Mary J Emond; Cyrus E Rubin; Teresa A Brentnall
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

8.  The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.

Authors:  Yasmin Hernandez; John Sotolongo; Keith Breglio; Daisy Conduah; Anli Chen; Ruliang Xu; David Hsu; Ryan Ungaro; Lory A Hayes; Cristhine Pastorini; Maria T Abreu; Masayuki Fukata
Journal:  BMC Gastroenterol       Date:  2010-07-16       Impact factor: 3.067

9.  Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors.

Authors:  Mary P Bronner; Marek Skacel; David A Crispin; Peter D Hoff; Mary J Emond; Lisa A Lai; Raymond R Tubbs; Jacintha N O'Sullivan; Peter S Rabinovitch; Teresa A Brentnall
Journal:  Mod Pathol       Date:  2010-08-27       Impact factor: 7.842

Review 10.  Field defects in progression to gastrointestinal tract cancers.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Katerina Dvorak; Harinder Garewal
Journal:  Cancer Lett       Date:  2007-12-31       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.